Efficacy of indole carbinol in patients with simple endometrial hyperplasia without atypia in perimenopause

1. Goldstein S.R., Lumsden M.A. Abnormal uterine bleeding in perimenopause. Climacteric. 2017; 20(5): 414–20. doi: 10.1080/13697137.2017.1358921.
2. Sanderson P.A., Critchley H.O., Williams A.R., Arends M.J., Saunders P.T. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017; 23(2): 232–54. doi: 10.1093/humupd/dmw042.
3. MacKintosh M.L., Derbyshire A.E., McVey R.J., Bolton J., Nickkho-Amiry M., Higgins C.L., Kamieniorz M., Pemberton P.W., Kirmani B.H., Ahmed B., Syed A.A., Ammori B.J., Renehan A.G., Kitchener H.C., Crosbie E.J. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. Int J Cancer. 2019; 144(3): 641–50. doi: 10.1002/ijc.31913.
4. Chandra V., Kim J.J., Benbrook D.M., Dwivedi A., Rai R. Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol. 2016; 27(1): e8. doi: 10.3802/jgo.2016.27.e8
5. Auclair M.H., Yong P.J., Salvador S., Thurston J., Colgan T.T.J., Sebastianelli A. Guideline No. 392-Classification and Management of Endometrial Hyperplasia. J Obstet Gynaecol Can. 2019; 41(12): 1789–1800. doi: 10.1016/j.jogc.2019.03.025.
6. Nieman K.M., Romero I.L., Van Houten B., Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 2013; 1831(10): 1533–41. doi: 10.1016/j.bbalip.2013.02.010.
7. Sahoo S.S., Lombard J.M., Ius Y., O’Sullivan R., Wood L.G., Nahar P., Jaaback K. Tanwar P.S. Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women. Mol Cancer Res. 2018; 16(2): 309–21. doi: 10.1158/1541-7786.MCR-17-0466.
8. Management of Endometrial Hyperplasia Green-top Guideline No. 67 RCOG/BSGE Joint Guideline. February, 2016.
9. Gerhauser C. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top Curr Chem. 2013; 329: 73–132. doi: 10.1007/128_2012_360.
10. Ашрафян Л.А., Бабаева Н.А., Антонова И.Б., Овчинникова О.А., Алешикова О.И., Моцкобили Т.А., Кузнецов И.Н. Уровень баланса эстрогенных метаболитов при раке молочной железы и пути его коррекции. Опухоли репродуктивной системы. 2015; 3: 22–9. [Ashrafyan L.A., Babaeva N.A., Antonova I.B., Ovchinnikova O.A., Aleshikova O.I., Motskobili T.A., Kuznetsov I.N. The balance of estrogen metabolites in breast cancer and the ways of its correction. Tumors of female reproductive system. 2015; 11(3): 22–9. (In Russ.)]. https://doi.org/10.17650/1994-4098-2015-11-3-22-29
11. Adwas A.A., Elkhoely A.A., Kabel A.M., Abdel-Rahman M.N., Eissa A.A. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. J Infect Chemother. 2016; 22(1): 36–43. doi: 10.1016/j.jiac.2015.10.001.
12. Wang S.Q., Cheng L.S., Liu Y., Wang J.Y., Jiang W. Indole-3-сarbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection. Curr Drug Metab. 2016; 17(4): 401–9. DOI: 10.2174/1389200217666151210125105
13. Perez-Chacon G., de Los Rios C., Zapata J.M. Indole-3-carbinol induces cMYC and IAP-family down modulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt’s lymphoma cell lines. Pharmacol Res. 2014; 89: 46–56. doi: 10.1016/j.phrs.2014.08.005.
14. Xiao X., Meng Q., Xu J., Jiao Y., Rosen E.M., Fan S. EGFR-dependent impact of indol-3-carbinol on radiosensitivity of lung cancer cells. Zhongguo Fei Ai Za Zhi. 2012; 15(7): 391–8. doi: 10.3779/j.issn.1009-3419.2012.07.01.
15. Kundu A., Khouri M.G., Aryana S., Firestone G.L. 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M. Carcinogenesis. 2017; 38(12): 1207–17. doi: 10.1093/carcin/bgx103.
16. Quirit J.G., Lavrenov S.N., Poindexter K., Xu J., Kyauk C., Durkin K.A., Aronchik I., Tomasiak T., Solomatin Y.A., Preobrazhenskaya M.N., Firestone G.L. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells. Biochem Pharmacol. 2017; 127: 13–27. doi: 10.1016/j.bcp.2016.12.007.
17. Kundu A., Quirit J.G., Khouri M.G., Firestone G.L. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation. Mol Carcinog. 2017; 56(1): 49–61. doi: 10.1002/mc.22472.
18. Tin A.S., Park A.H., Sundar S.N., Firestone G.L. Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells. BMC Biol. 2014; 12: 72. doi: 10.1186/s12915-014-0072-6.
19. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W., Sherman Sh., Sluss P.M., de Villiers T.J., for the STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19(4): 387–95. doi: 10.1097/gme.0b013e31824d8f40
20. Chinni S.R., Sarkar F.H. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clinical Cancer Research. 2002; 8: 1228–36. PMID: 11948137
21. Will A.J., Sanchack K.E. Endometrial Biopsy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020-2019 May 5. PMID: 31082179
22. Ашрафян Л.А., Киселев В.И., Кузнецов И.Н., Муйжнек Е.Л., Герфанова Е.В., Вашакмадзе С.Л. Молекулярная онкобиология и перспективы эффективной терапии. Онкология. Журнал им. П.А.Герцена. 2016; 5(3): 80–7. [Ashrafyan L.A., Kiselev V.I., Kuznetsov I.N., Muizhnek E.L., Gerfanova E.V., Vashakmadze S.L. Molecular cancer biology and prospects for effective therapy. P.A. Herzen Journal of Oncology=Onkologiya. Zhurnal imeni P.A. Gertsena. 2016; 5(3): 80–7. (in Russ.)]. https://doi.org/10.17116/onkolog20165280-87
23. Ашрафян Л.А., Киселев В.И. Скрининг и ранняя диагностика рака репродуктивных органов. М.: Молодая гвардия, 2016. 244 c. [Ashrafyan L.A., Kiselev V.I. Screening and early diagnostics of cancers of reproductive organs. М.: Molodaya gvardiya, 2016. 244 р. (in Russian)].
24. Савельева Г.М., Сухих Г.Т., Серов В.Н., Радзинский В.Е., Манухин И.Б., ред. Гинекология: национальное руководство. М.: ГЭОТАР-Медиа, 2017. 1008 с. [Savelyeva G.M., Sukhikh G.T., Serova V.N., Radzinsky V.E., Manukhin I.B., ed. Gynecology: national leadership. M.: GEOTAR-Media, 2017. 1008p. (in Russ.)].
25. Киселев В.И., Сметник В.П., Сутурина Л.В., Селиванов С.П., Рудакова Е.Б., Рахматуллина И.Р.; Андреева Е.Н., Фадеева Н.И., Хасанов Р.Ш., Кулагина Н.В., Рожкова Н.И., Артымук Н.В., Гависова  А.А., Муйжнек Е.Л., Кузнецов И.Н., Друх В.М. Индолкарбинол (Индинол Форто) – метод мультитаргетной терапии при циклической мастодинии. Акушерство и гинекология. 2013; 7: 56–62. [Kiselev V.I.,Smetnik V.P., Suturina L.V., Selivanov S.P., Rudakova E.B., Rakhmatullina I.R., Andreyeva E.N., Fadeyeva N.I., Khasanov R.Sh., Kulagina N.V., Rozhkova N.I., Artymuk N.V., Gavisova A.A., Muizhnek E.L., Kuznetsov I.N., Drukh V.M. Indole carbinol (Indinol Forto) is a multitargeted therapy option for cyclic mastodynia. Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2013; 7: 56–62. (In Russ.)].
26. Сметник В.П., Гависова А.А., Билак Н.П., Друх В.М. Эффективность индолкарбинола при циклической мастодинии. Проблемы репродукции. 2013; 5: 49–53. [Smetnik V.P., Gavisova A.A., Bilak N.P., Drukh V.M. Indole carbinol efficiency in cyclic mammalgia. Problems of reproduction. 2013; 5: 49–53. (in Russian)].
27. Tsiskarishvili N.V., Nadareishvili L.N., Tsiskarishvili Ts.I. New possibilities for elimination of human papillomavirus from the organism. Georgian Med News. 2011; (192): 34–8. [n Russ.]. PMID: 21525537

Received 16.01.2020

Accepted 07.02.2020